End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
103.95 CHF | +0.19% | -3.08% | +12.99% |
11-21 | Robertet: Fonds Stratégique de Participations tops 5% mark | CF |
11-21 | DSM-Firmenich Exits Stake in Fragrances, Flavors Company Robertet | MT |
Capitalization | 27.58B 29.1B 25.66B 22.9B 40.76B 2,461B 44.68B 318B 118B 1,009B 109B 107B 4,379B | P/E ratio 2024 * |
59.4x | P/E ratio 2025 * | 35x |
---|---|---|---|---|---|
Enterprise value | 30.64B 32.33B 28.5B 25.44B 45.29B 2,734B 49.64B 353B 131B 1,122B 121B 119B 4,865B | EV / Sales 2024 * |
2.39x | EV / Sales 2025 * | 2.26x |
Free-Float |
25.03% | Yield 2024 * |
2.4% | Yield 2025 * | 2.47% |
Last Transcript: DSM-Firmenich
1 day | +0.19% | ||
1 week | -3.08% | ||
1 month | -4.72% | ||
3 months | -15.49% | ||
6 months | -1.61% | ||
Current year | +12.99% |
Director | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/12/2019 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 31/08/2023 |
Ipek Ozsuer
CTO | Chief Tech/Sci/R&D Officer | 44 | 30/04/2023 |
Manager | Title | Age | Since |
---|---|---|---|
Thomas Leysen
CHM | Chairman | 64 | 31/01/2023 |
Director/Board Member | 62 | 31/01/2023 | |
André Pometta
BRD | Director/Board Member | 59 | 31/01/2023 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.82% | 12 M€ | +15.09% | - | |
0.51% | 10 M€ | +6.14% | - | |
0.22% | 4 M€ | -.--% | - | |
0.20% | 6 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.19% | -3.08% | +19.66% | - | 29.1B | ||
+0.07% | +1.37% | +32.63% | +73.68% | 1,041B | ||
-0.02% | -0.25% | +0.63% | +163.78% | 240B | ||
+1.43% | +1.67% | +18.89% | +15.18% | 151B | ||
+0.54% | +1.30% | +14.58% | +19.54% | 81.95B | ||
+0.79% | +3.98% | +34.78% | -21.47% | 72.71B | ||
-1.41% | -4.83% | +165.78% | +758.06% | 49.1B | ||
-0.29% | -1.43% | +26.78% | +78.80% | 35.12B | ||
+0.52% | +3.22% | -41.18% | -59.65% | 31.42B | ||
+1.33% | +0.62% | +3.84% | -10.61% | 21.57B | ||
Average | +0.32% | +0.30% | +27.64% | +113.04% | 175.38B | |
Weighted average by Cap. | +0.20% | +1.00% | +28.03% | +90.60% |
2024 * | 2025 * | |
---|---|---|
Net sales | 12.82B 13.52B 11.93B 10.64B 18.95B 1,144B 20.77B 148B 54.98B 469B 50.81B 49.68B 2,035B | 13.36B 14.1B 12.43B 11.1B 19.75B 1,192B 21.65B 154B 57.32B 489B 52.97B 51.79B 2,122B |
Net income | 471M 497M 438M 391M 696M 42.03B 763M 5.43B 2.02B 17.24B 1.87B 1.83B 74.79B | 811M 856M 755M 674M 1.2B 72.4B 1.31B 9.35B 3.48B 29.7B 3.22B 3.14B 129B |
Net Debt | 3.06B 3.23B 2.85B 2.54B 4.53B 273B 4.96B 35.27B 13.13B 112B 12.14B 11.87B 486B | 2.69B 2.84B 2.5B 2.24B 3.98B 240B 4.36B 31.01B 11.55B 98.53B 10.67B 10.43B 427B |
Date | Price | Change | Volume |
---|---|---|---|
29/11/24 | 103.95 CHF | +0.19% | 419,183 |
28/11/24 | 103.75 CHF | -0.77% | 229,820 |
27/11/24 | 104.55 CHF | -0.33% | 341,188 |
26/11/24 | 104.90 CHF | -1.36% | 344,978 |
25/11/24 | 106.35 CHF | -0.84% | 1,377,450 |
End-of-day quote Euronext Amsterdam, November 28, 2024
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- DSFIR Stock
MarketScreener is also available in this country: United States.
Switch edition